Clinical Trials Logo

Clinical Trial Summary

This study aimed to assess the effectiveness of the ultrasound-guided interfascial injection approach with the subpectineal injection technique for obturator nerve block in bladder cancers undergoing transurethral resection of bladder tumor (TURBT) under spinal anesthesia.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05540847
Study type Interventional
Source Diskapi Teaching and Research Hospital
Contact
Status Completed
Phase N/A
Start date September 16, 2022
Completion date April 23, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT04081246 - Transurethral Modified En Bloc Resection For Large Bladder Tumours. N/A
Terminated NCT00249301 - A Study of MLN8054 in Patients With Advanced Solid Tumors Phase 1
Recruiting NCT06167356 - Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK.
Terminated NCT01200992 - Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer Phase 3
Recruiting NCT04839029 - Bipolar Versus Mono-polar Needlescopic En Bloc TUR-BT N/A
Active, not recruiting NCT03138824 - Storz Professional Image Enhancement System Versus White Light Imaging Assisted TURBT for Treatment of NMIBC N/A
Completed NCT03013894 - Confocal Laser Endomicroscopy in the Lower Urinary Tract
Completed NCT00722553 - Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder Phase 2
Active, not recruiting NCT04167631 - Can VI-RADS/ADC Accurately Stage Bladder Cancer?? N/A
Completed NCT03458598 - Pre-Operative Single Shot Rectus Sheath Block N/A
Recruiting NCT04075305 - The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Not yet recruiting NCT05134623 - Smurf2 Gene Expression in Urinary Tract Tumors
Completed NCT04200963 - A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma Phase 1
Not yet recruiting NCT05467267 - Personalized Urine Biomarker for Patients With Bladder Cancer
Recruiting NCT05022160 - Preventing Catheter Related Bladder Discomfort (CRBD) With Bilateral Pudendal Nerve Block Early Phase 1
Completed NCT03591367 - The Potential Role Of MicroRNA-155 And Telomerase Reverse Transcriptase In Diagnosis Of Non-Muscle Invasive Bladder Cancer And Their Pathological Correlation N/A
Terminated NCT03335059 - Mitomycin C Intravesical Chemotherapy in Conjunction With Synergo® Radiofrequency-Induced Hyperthermia for Treatment of Carcinoma in Situ Non-Muscle Invasive Bladder Cancer Patients Unresponsive to Bacillus Calmette-Guérin, With or Without Papillary Tumors. Phase 3
Recruiting NCT05027412 - En Bloc TURBT With Collins Loop vs Conventional TURBT N/A
Recruiting NCT04784507 - En-Bloc Resection of Bladder Tumors Phase 2